Company USA
The company commercializes products developed utilizing its proprietary Platform. The platform is an enabling reformulation technology which provides low cost solutions to extend the life cycle of blockbuster drugs, as well as to become a cornerstone drug delivery technique for new chemical entities. The Platform provides a simple and scalable process to reformulate a range of different drugs.
Access the contact details for this post by subscribing to premium content membership. For more details on premium content membership see our membership and fees page >> or contact info@nanoposts.com, Tel: +44(0)1786 474768.
|
||
| CLICK HERE If you would like to receive contact details for this technology provider or ask a question (s) |
|
Privacy Statement | Terms of Use
T: +44 (0) 1786 474768 E: info@nanoposts.com |
|||||